Breaking News Instant updates and real-time market news.

GWW

Grainger

$285.60

-3.88 (-1.34%)

20:11
12/10/18
12/10
20:11
12/10/18
20:11

Grainger initiated with a Neutral at Buckingham

Buckingham Research analyst Robert Barry initiated Grainger with a Neutral rating and a price target of $325, anticipating 12% EPS growth in 2019 but "little opportunity" for multiple expansion. The analyst notes that the current valuation on the stock is "reasonable" but not "compelling", even though he is positive on company's "defensive characteristics" at the current "advanced stage" of the U.S. macro cycle. Barry further states that Grainger's Q4 guidance is likely to be consistent with the Street consensus.

  • 24

    Jan

GWW Grainger
$285.60

-3.88 (-1.34%)

10/17/18
LBOW
10/17/18
NO CHANGE
LBOW
Neutral
Grainger selloff may be overdone, says Longbow
Longbow analyst Chris Dankert believes Grainger selloff may be overdone. The analyst notes that numerous factors coalesced to drag on shares as concerns about organic U.S. operating leverage, and the poorly telegraphed curtailment of guidance met plateauing large-customer growth and GM headwinds. However, Dankert believes the shares may be more interesting on the long side now as ongoing restructuring savings, robust medium customer growth, and positive pricing should drive EPS above the guidance range. The analyst sees the risk-reward beginning to shift favorably. He reiterates a Neutral rating on the shares.
10/17/18
OPCO
10/17/18
NO CHANGE
Target $355
OPCO
Outperform
Grainger price target lowered to $355 from $410 at Oppenheimer
Oppenheimer analyst Christopher Glynn lowered his price target for Grainger to $355 from $410 after the shares sold off 12% on lack of a clear raise, and EPS from an operating contribution perspective a bit below estimates. The analyst believes the selloff looks "overdone," and reiterates an Outperform rating on the shares.
10/12/18
GDHS
10/12/18
INITIATION
Target $337
GDHS
Hold
Grainger initiated with a Hold at Gordon Haskett
Gordon Haskett analyst John Inch started Grainger with a Hold rating and $337 price target.
09/26/18
BMOC
09/26/18
NO CHANGE
Target $330
BMOC
Market Perform
Grainger's market-based pricing 'successfully driving sales', says BMO Capital
BMO Capital analyst R. Scott Graham kept his Market Perform rating and $330 price target on Grainger after hosting a conference call with its management which addressed the company's "pricing, competitive landscape, operating environment, and tariffs". The analyst says the company's U.S. pricing has been reset by the "price transparency brought to the MRO market by Google", adding that its change to market-based pricing is driving sales. Graham also notes that Grainger has built dedicated teams to "understand competitive sets by product group" and another team "working diligently to assess the impact of tariffs on its business".

TODAY'S FREE FLY STORIES

LKFN

Lakeland Financial

$47.28

0.13 (0.28%)

11:02
11/12/19
11/12
11:02
11/12/19
11:02
Hot Stocks
Lakeland Financial appoints Rick Donovan as General Counsel »

Lake City Bank announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:01
11/12/19
11/12
11:01
11/12/19
11:01
Conference/Events
Wedbush tech strategist to hold an analyst/industry conference call »

Technology Strategist…

RUN

Sunrun

$14.61

0.2 (1.39%)

10:55
11/12/19
11/12
10:55
11/12/19
10:55
Options
Sunrun put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 04

    Dec

10:55
11/12/19
11/12
10:55
11/12/19
10:55
Conference/Events
Economic Club of New York to host President Trump »

President Trump to…

DOX

Amdocs

$67.14

0.12 (0.18%)

10:54
11/12/19
11/12
10:54
11/12/19
10:54
Conference/Events
Amdocs management to meet with JPMorgan »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 14

    Nov

VRTX

Vertex

$203.56

1.66 (0.82%)

10:53
11/12/19
11/12
10:53
11/12/19
10:53
Hot Stocks
Vertex confirms Northern Ireland offer accepted for cystic fibrosis medicines »

Vertex Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

ABBV

AbbVie

$87.46

1.82 (2.13%)

, AGN

Allergan

$182.96

2.92 (1.62%)

10:52
11/12/19
11/12
10:52
11/12/19
10:52
Periodicals
AbbVie preps $27B bond sale to finance Allergan deal, FT reports »

AbbVie (ABBV) is readying…

ABBV

AbbVie

$87.46

1.82 (2.13%)

AGN

Allergan

$182.96

2.92 (1.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

CMBM

Cambium Networks

$7.67

(0.00%)

10:51
11/12/19
11/12
10:51
11/12/19
10:51
Conference/Events
Cambium Networks management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

AER

AerCap

$61.01

0.72 (1.19%)

10:50
11/12/19
11/12
10:50
11/12/19
10:50
Conference/Events
AerCap management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

WBA

Walgreens Boots Alliance

$62.35

0.09 (0.14%)

10:46
11/12/19
11/12
10:46
11/12/19
10:46
Recommendations
Walgreens Boots Alliance analyst commentary  »

Walgreens Boots could be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 22

    Nov

QSR

Restaurant Brands

$67.39

-0.15 (-0.22%)

10:45
11/12/19
11/12
10:45
11/12/19
10:45
Options
Restaurant Brands call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:45
11/12/19
11/12
10:45
11/12/19
10:45
General news
Breaking General news story  »

4-Week Bill Announcement…

10:45
11/12/19
11/12
10:45
11/12/19
10:45
General news
Breaking General news story  »

8-Week Bill Announcement…

F

Ford

$9.11

0.03 (0.33%)

, GM

General Motors

$38.89

0.18 (0.46%)

10:38
11/12/19
11/12
10:38
11/12/19
10:38
Periodicals
Trump expected to extend deadline for EU car tariffs, Bloomberg says »

The Trump administration…

F

Ford

$9.11

0.03 (0.33%)

GM

General Motors

$38.89

0.18 (0.46%)

HMC

Honda

$29.35

0.15 (0.51%)

NSANY

Nissan

$0.00

(0.00%)

TM

Toyota

$145.00

-0.07 (-0.05%)

TSLA

Tesla

$348.78

3.71 (1.08%)

DDAIF

Daimler AG

$0.00

(0.00%)

FCAU

Fiat Chrysler

$16.21

0.1 (0.62%)

VWAGY

Volkswagen

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 09

    Dec

  • 04

    Feb

KSS

Kohl's

$56.48

-0.56 (-0.98%)

10:35
11/12/19
11/12
10:35
11/12/19
10:35
Options
Kohl's put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

10:35
11/12/19
11/12
10:35
11/12/19
10:35
General news
FX Action: USD-JPY »

FX Action: USD-JPY…

DIS

Disney

$139.04

2.3 (1.68%)

10:31
11/12/19
11/12
10:31
11/12/19
10:31
Hot Stocks
Disney says Disney+ 'exceeded our high expectations,' working on glitches »

Disney+ Help tweeted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KHC

Kraft Heinz

$32.77

0.01 (0.03%)

10:25
11/12/19
11/12
10:25
11/12/19
10:25
Options
Kraft Heinz call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHHBY

Roche

$0.00

(0.00%)

10:25
11/12/19
11/12
10:25
11/12/19
10:25
Conference/Events
Roche to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 12

    Nov

  • 07

    Dec

REPL

Replimune Group

$17.24

0.11 (0.64%)

10:25
11/12/19
11/12
10:25
11/12/19
10:25
Conference/Events
Replimune Group participates in a conference call with JPMorgan »

SMid Biotech Analyst Rama…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 12

    Nov

10:25
11/12/19
11/12
10:25
11/12/19
10:25
Conference/Events
UBS technology analysts to hold an analyst/industry conference call »

Technology Analysts…

LH

LabCorp

$165.45

-0.29 (-0.17%)

10:23
11/12/19
11/12
10:23
11/12/19
10:23
Syndicate
Breaking Syndicate news story on LabCorp »

LabCorp files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRWD

Crowdstrike

$47.57

1.39 (3.01%)

, TEVA

Teva

$9.36

0.03 (0.32%)

10:21
11/12/19
11/12
10:21
11/12/19
10:21
On The Fly
JPMorgan gets less bearish on Xerox among today's top calls on Wall Street »

Check out today's top…

CRWD

Crowdstrike

$47.57

1.39 (3.01%)

TEVA

Teva

$9.36

0.03 (0.32%)

AMRX

Amneal Pharmaceuticals

$2.69

0.05 (1.89%)

XRX

Xerox

$38.05

-0.28 (-0.73%)

HPQ

HP Inc.

$19.33

-0.31 (-1.58%)

AMAT

Applied Materials

$56.81

0.21 (0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 20

    Nov

  • 26

    Nov

  • 05

    Dec

  • 07

    Dec

  • 09

    Dec

  • 09

    Dec

  • 12

    Dec

UCBJY

UCB

$0.00

(0.00%)

10:20
11/12/19
11/12
10:20
11/12/19
10:20
Conference/Events
UCB participates in a conference call with JPMorgan »

European Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$19.92

3.02 (17.87%)

10:18
11/12/19
11/12
10:18
11/12/19
10:18
On The Fly
Analysts see good odds of Amarin's Vascepa label expansion after docs posted »

Stifel analyst Derek…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 28

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.